Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-15.08
Price to sales ratio

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1872
AGIO
Agios Pharmaceuticals, Inc. - Common Stock
40.55 USD-1.65%+2.35%+36.58%-6.55%2.41 B USD
1885
NRIX
Nurix Therapeutics, Inc. - Common stock
22.71 USD-1.52%-5.65%+32.81%+102.59%2.36 B USD
1888
TRVI
Trevi Therapeutics, Inc. - Common Stock
16.52 USD-7.40%-8.63%+14.64%+134.99%2.35 B USD
1898
NKTR
Nektar Therapeutics - Common Stock
68.32 USD-2.90%-6.60%+13.36%-6.76%2.31 B USD

Frequently asked questions about SELLAS Life Sciences Group, Inc. - Common Stock

What is the SELLAS Life Sciences Group, Inc. - Common Stock stock price today?

The current price of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) is 12.62. Over the past 24 hours, the stock has changed by -1.10%. Follow the SLS chart for real-time price dynamics.

What is the stock ticker of SELLAS Life Sciences Group, Inc. - Common Stock?

SELLAS Life Sciences Group, Inc. - Common Stock trades under the ticker SLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is SELLAS Life Sciences Group, Inc. - Common Stock stock going up?

SLS has changed by -9.21% over the last week, +59.75% over the last month, and +540.61% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does SELLAS Life Sciences Group, Inc. - Common Stock release financial reports?

Yes. You can track SELLAS Life Sciences Group, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was SELLAS Life Sciences Group, Inc. - Common Stock net income for the last quarter?

SELLAS Life Sciences Group, Inc. - Common Stock reported net income of -8.41 M for the last quarter. The previous quarter showed -7.66 M, which means net income changed by -9.78%.

How many employees does SELLAS Life Sciences Group, Inc. - Common Stock have?

As of the latest available data, SELLAS Life Sciences Group, Inc. - Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy SELLAS Life Sciences Group, Inc. - Common Stock stock?

You can buy SELLAS Life Sciences Group, Inc. - Common Stock (SLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in SELLAS Life Sciences Group, Inc. - Common Stock stock?

Investing in SELLAS Life Sciences Group, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLS chart and related analysis on metatrader.com as part of your research.

News